Previous 10 | Next 10 |
B Riley has resumed coverage of Lantheus Holdings ( NASDAQ: LNTH ) with a buy citing the company's growth trajectory due to the the launch of Pylarify, a prostate-specific membrane antigen (PSMA) targeting positron emission tomography ( PET ) imaging agent. The firm ha...
Earnings season winds down after producing the best S&P performance since 2009. The recently passed tax and spend green energy bill does not contain a scintilla of "growth". That means any recovery remains rocky at best. China's zero COVID policy continues to take its toll on ...
Stock market expectations have shifted to a relatively more benign Federal Reserve rate outlook, thus driving a sharp rally. The market is approaching a key technical level. Healthcare has relatively outperformed the market and has been consolidating. Biotechs found a bottom a...
As the market begins to show signs of recovery in the second half of 2022, there are 3 growth stocks that are offering investors a chance to realize capital appreciation. AerSale is about to commercialize its AerAware heads-up aircraft cockpit display technology and has realized a 72%...
Lantheus Holdings, Inc. (LNTH) Q2 2022 Earnings Conference Call Aug 4, 2022 8:08 AM Company Participants Mark Kinarney - Senior Director, Investor Relations Mary Heino - President and Chief Executive Officer Robert Marshall - Chief Financial Officer and Treasurer...
The following slide deck was published by Lantheus Holdings, Inc. in conjunction with their 2022 Q2 earnings call. For further details see: Lantheus Holdings, Inc. 2022 Q2 - Results - Earnings Call Presentation
The biotech industry for the first half of the year had seen better six-month periods in the past, but the situation appears to have changed beginning in July. From Jan. 1 to June 20, 2022, the SPDR S&P Biotech ETF ( XBI ) and iShares Nasdaq Biotechnology ETF ( IBB ) had...
Lantheus press release ( NASDAQ: LNTH ): Q2 Non-GAAP EPS of $0.89 beats by $0.19 . Revenue of $223.72M (+121.4% Y/Y) beats by $19.21M . Net cash provided by operating activities was $72.6 million for the second quarter 2022. Free cash flow was $68.3 million in ...
NORTH BILLERICA, Mass., July 21, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, August 4, 2022, to discuss its financial and operating results for ...
Optimism about incoming corporate results and easing fears about Federal Reserve policy provided the backdrop for stocks to post another positive session on Wednesday. The Nasdaq led the advance, which built on a broad-based rally staged during the previous day. Wednesday's gains includ...
News, Short Squeeze, Breakout and More Instantly...
Lantheus Holdings Inc. Company Name:
LNTH Stock Symbol:
NASDAQ Market:
Lantheus Holdings Inc. Website:
BEDFORD, Mass., July 17, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Wednesday, July 31, 2024, to discuss its financial and operating results for the second...
BEDFORD, Mass., July 15, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced its acqu...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 5.6% to $127.4 on volume of 368,729,821 shares Maxeon Solar Technologies Ltd. (MAXN) rose 14.2% to $0.2407 on volume of 294,399,898 shares Kazia Therapeutics Limited (KZIA) rose 85.6% to $1.24 on volume ...